156 related articles for article (PubMed ID: 1520771)
1. Antiendotoxin monoclonal antibodies for gram-negative sepsis.
Chmel H; Emmanuel G
Clin Infect Dis; 1992 Aug; 15(2):371-2. PubMed ID: 1520771
[No Abstract] [Full Text] [Related]
2. Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA.
Wenzel RP; Andriole VT; Bartlett JG; Batt MD; Bullock WE; Cobbs CG; Light B; Martin MA; Sanford J; Sande MA
Clin Infect Dis; 1992 Apr; 14(4):973-6. PubMed ID: 1482434
[No Abstract] [Full Text] [Related]
3. Antiendotoxin antibodies.
Siegel JP
Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
[No Abstract] [Full Text] [Related]
4. Antiendotoxin antibodies: a dead end?
Cross AS
Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
[No Abstract] [Full Text] [Related]
5. Antibody to endotoxin in the treatment of gram-negative sepsis.
Schentag JJ
JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766
[No Abstract] [Full Text] [Related]
6. Monoclonal antibodies for gram-negative sepsis.
Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976
[No Abstract] [Full Text] [Related]
7. Antibody to endotoxin in the treatment of gram-negative sepsis.
Spalter J
JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764
[No Abstract] [Full Text] [Related]
8. Antibody to endotoxin in the treatment of gram-negative sepsis.
McCabe WR
JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
[No Abstract] [Full Text] [Related]
9. Antibody to endotoxin in the treatment of gram-negative sepsis.
van Deventer S
JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
[No Abstract] [Full Text] [Related]
10. Anti-endotoxin monoclonal antibodies.
Ziegler EJ; Smith CR
N Engl J Med; 1992 Apr; 326(17):1165. PubMed ID: 1552929
[No Abstract] [Full Text] [Related]
11. Anti-endotoxin monoclonal antibodies.
Warren HS; Danner RL; Munford RS
N Engl J Med; 1992 Apr; 326(17):1153-7. PubMed ID: 1552919
[No Abstract] [Full Text] [Related]
12. Anti-endotoxin monoclonal antibodies--a second look.
Wenzel RP
N Engl J Med; 1992 Apr; 326(17):1151-3. PubMed ID: 1552918
[No Abstract] [Full Text] [Related]
13. [A cost-effectiveness analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].
Tebas P
Med Clin (Barc); 1993 Dec; 101(19):757-8. PubMed ID: 8289526
[No Abstract] [Full Text] [Related]
14. Lessons learned from clinical trials on monoclonal anti-endotoxin antibody.
Weil MH
Arch Intern Med; 1994 Jun; 154(11):1183. PubMed ID: 8203986
[No Abstract] [Full Text] [Related]
15. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
Barriere SL; Guglielmo BJ
Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
[TBL] [Abstract][Full Text] [Related]
16. Projected impact of monoclonal anti-endotoxin antibody therapy.
Bates DW; Lee TH
Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
[TBL] [Abstract][Full Text] [Related]
17. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
18. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of severe gram-negative bacterial infections. Centoxin: a new drug under monitoring. National Committee for the Evaluation of Centoxin].
Pathol Biol (Paris); 1992 Dec; 40(10):975-6. PubMed ID: 1299810
[No Abstract] [Full Text] [Related]
20. Human monoclonal antibodies in sepsis.
Smith C; Straube R; Wortel C
Neth J Med; 1991 Oct; 39(3-4):177-9. PubMed ID: 1824049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
